3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Lung Neoplasms
2
Breast Neoplasms
2
Vitamin D Deficiency
1
Tobacco Use Disorder
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pneumonia
1
Obesity
1
Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Leukemia
1
Crohn Disease
1
Castration-resistant Prostate Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Arthritis, Rheumatoid
1
Alopecia
1
Interventions
Temozolomide
7
Magnetic Resonance Spectroscopy
7
X-Rays
5
Phantoms, Imaging
5
Bevacizumab
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Carboplatin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Lapatinib
2
LY3023414
2
Everolimus
2
Etoposide
2
Erlotinib Hydrochloride
2
veliparib
1
pomalidomide
1
poly ICLC
1
picropodophyllin
1
marizomib
1
imetelstat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ependymoma
×
Calcitriol
×
Clear all
No trials found.